PUBLICAÇÕES científicas

/cun/pt/investigacion/publicaciones-cientificas/areaMain/02
  • Toxicity and biodistribution of orally administered casein nanoparticles

    Gil AG (1), Irache JM (2), Peñuelas I (3), González Navarro CJ (4), López de Cerain A (5). 1 (a) Department of Pharmacology and Toxicology, Drug Development Unit, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.
    2 (b) Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.
    3 (c) Radiopharmacy Unit, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
    4 (d) Centro Nacional de Tecnología y Seguridad Alimentaria, 31570, San Adrian, Spain.
    5 (a) Department of Pharmacology and Toxicology, Drug Development Unit, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.

    Food and Chemichal Toxicology 14 de JUNHO de 2017

  • Plasma rich in growth factors for the treatment of rapidly progressing refractory corneal melting due to erlotinib in nonsmall cell lung cancer

    Guarnieri A (1), Alfonso-Bartolozzi B, Ciufo G, Moreno-Montañés JGil-Bazo I. (a) Department of Ophthalmology
    (b) Department of Oncology, Clínica Universidad de Navarra, Navarre, Spain

    Medicine 02 de JUNHO de 2017

  • Subclinical Antibody-Mediated Rejection

    Arias M (1), Serón D, Herrero I, Rush DN, Wiebe C, Nickerson PW, Ussetti P, Rodrigo E, de Cos MA. (1) Nephrology Department, Hospital Universitario Marqués de Valdecilla-IDIVAL, Universidad de Cantabria, Santander, Spain.
    (2) Department of Nephrology, Hospital Universitari Vall D´Hebrón, Universidad Autónoma de Barcelona, Barcelona, Spain.
    (3) Liver Unit, Clínica Universidad de Navarra, Biomedical Research Centre in the Liver and Digestive Diseases Network (CIBERehd), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra, Spain.
    (4) Section of Nephrology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
    (5) Department of Neumology, Clínica Puerta de Hierro, Madrid, Spain.
    (6) Clinical Pharmacology Service, Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Spain.

    Transplantation 01 de JUNHO de 2017

  • Eligibility and Success Criteria for Bariatric/Metabolic Surgery

    Landecho MF (1), Valentí V (2,3), Moncada R (2,4), Frühbeck G (5,6). (1) Department of Internal Medicine, Clínica Universidad de Navarra, TRUE-HT, University of Navarra, IdISNA, Avda. Pío XII, 36, Pamplona, 31008, Spain.
    (2) CIBEROBN, Instituto de Salud Carlos III, Avda. Pío XII, 36, Pamplona, 31008, Spain.
    (3) Department of Surgery, Clínica Universidad de Navarra, University of Navarra, IdISNA, Avda. Pío XII, 36, Pamplona, 31008, Spain.
    (4) Department of Anesthesia, Clínica Universidad de Navarra, University of Navarra, IdISNA, Avda. Pío XII, 36, Pamplona, 31008, Spain.
    (5) CIBEROBN, Instituto de Salud Carlos III, Avda. Pío XII, 36, Pamplona, 31008, Spain.
    (6) Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, University of Navarra, IdISNA, Avda. Pío XII, 36, Pamplona, 31008, Spain.

    Advances in Experimental Medicine and Biology 01 de JUNHO de 2017

  • 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome

    García Vicente AM (1), Delgado-Bolton RC (2), Amo-Salas M (3), López-Fidalgo J (4), Caresia Aróztegui AP (5), García Garzón JR (6), Orcajo Rincón J (7), García Velloso MJ (8), de Arcocha Torres M (9), Alvárez Ruíz S (10); Oncology Task Force of Spanish Society of Nuclear Medicine and Molecular Imaging. (1) Nuclear Medicine Department, University General Hospital, C/ Obispo Rafael Torija s/n, 13005, Ciudad Real, Spain. angarvice@yahoo.es.
    (2) Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, San Pedro Hospital and Centre for Biomedical Research of La Rioja (CIBIR), University of La Rioja, Logroño, Spain.
    (3) Department of Mathematics, University of Castilla-La Mancha, Ciudad Real, Spain.
    (4) Universidad de Navarra, ICS, Unidad de Estadística, Campus Universitario, 31080, Pamplona, Spain.
    5 Nuclear Medicine Department, Parc Taulí Hospital Universitari, Sabadell, Barcelona, Spain.
    (6) Unitat PET/TC CETIR-ERESA, Barcelona, Spain.
    (7) Nuclear Medicine Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
    (8) Nuclear Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain.
    (9) Nuclear Medicine Department, Hospital Universitario Marques de Valdecilla, Santander, Spain.
    (10) Nuclear Medicine Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.

    European Journal of Nuclear Medicine and Molecular Imaging 27 de MAIO de 2017

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra